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1. Introduction 
DNA synthesis in differentiating cardiac muscle of 
the rat decreases progressively following birth and 
essentially ceases by the middle of the third week of 
postnatal development [l] . The activity of nuclear 
poly(ADP-ribose) polymerase (an enzyme which 
catalyzes a reaction involving the sequential transfer 
of the ADP-ribose moiety of NAD to chromosomal 
proteins resulting in the formation of a homopolymer 
of ADP-ribose residues and the release of nicotin- 
amide) and the intracellular concentration of NAD 
increase progressively in cardiac muscle during this 
same period of development and it was suggested 
that NAD and poly(ADP-ribose) polymerase were 
involved with the repression of DNA replication in 
this tissue [2]. The studies reported in this com- 
munication were undertaken in ordkr to investigate 
this possibility. 
2. Materials and methods 
Timed pregnant rats were obtained from Holtzman 
(Madison, Wisconsin) on the 14th day of gestation. 
They were housed in individual cages and maintained 
on water and standard laboratory chow ad libitum. 
Neonatal rats were raised in litters of ten. 
Tissue slices of ventricular cardiac muscle were 
prepared with a Stadie-Riggs tissue slicer. Approxi- 
mately 150 mg of tissue was incubated at 37’C in 
5 ml of Eagle’s minimum essential medium containing 
Hanks’ salt base with 5 /.&i/ml [3H] thymidine (spec. 
act. of 17 Ci/mmol, Amersham/Searle). At the end of 
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the incubation period the tissue was homogenized in 
0.15 M NaCl and DNA synthesis was estimated by 
measuring the incorporation of [3H] thymidine into 
DNA as previously described [ 13. [3H] Thymidine 
incorporation under these incubation conditions is 
linear for at least 4 h. 
Thymidine transport was determined by measuring 
the uptake of [3H] thymidine into the acid-soluble 
fraction of cardiac muscle. Slices were incubated as 
above then washed twice in 0.15 M NaCl, blotted dry 
and homogenized in 2.0 ml of 0.15 M NaCl. An equal 
volume of ice-cold 10% perchloric acid was added 
and the acid-soluble radioactivity was measured as 
described [l] . 
3. Results 
NAD added to tissue slices of differentiating 
cardiac muscle inhibits the incorporation of [3H] 
thymidine into DNA in a concentration-dependent 
manner (fig.l). A time study of this inhibition and 
the effect of NAD on thymidine transport are shown 
in fig.2. NAD inhibits [3H] thymidine incorporation 
into DNA progressively during the incubation period 
but has little effect on [3H] thymidine transport. The 
inhibition of [3H] thymidine incorporation by NAD 
is specific since other related pyridine nucleotides 
have little effect on incorporation (table 1). The 
inhibition observed with NADH may be due to its 
oxidation to NAD. 
4. Discussion 
The terminally differentiated ventricular cardiac 
muscle cell of the adult mammal exists in a repressed 
231 
Volume 6 1, number 2 FEBS LETTERS January 1976 
1 1 I 
10-6 10-4 10-2 
~AD]h!OLAR 
Fig.1. Effect of NAD on [ aHI thymidine incorporation into 
DNA of tissue slices of differentiating cardiac muscle. Tissue 
slices were prepared from 5-day-old neonatal rats and incubated 
for 2 h. 
state in that it has irreversibly lost the ability to 
replicate its DNA, undergo mitosis and divide [ 1,3,4] . 
Little is known about the mechanisms responsible 
for this loss of synthetic activity. Recently it was 
observed that as the rate of DNA synthesis decreases 
in differentiating cardiac muscle intracellular levels of 
NAD are elevated and the activity of the nuclear 
enzyme which converts NAD to poly(ADP-ribose) is 
increased [2]. Data presented in the present communi- 
cation show that NAD inhibits DNA synthesis when 
added to tissue slices of differentiating cardiac muscle. 
Table 1 
Effect of NAD, related pyridine nucleotides and 
nicotinamide on [ 3H] thymidine incorporation into DNA 
of tissue slices prepared from differentiating cardiac muscle. 
Addition [aHj thymidine incorporation 
(% of control) 
NAD 69 
NADH 88 
NADP 98 
NADPH 92 
NMN 98 
Nicotinamide 97 
Tissue slices were prepared from cardiac muscle of 4-day-old 
neonatal rats and incubated for 2 h with the indicated com- 
pound at a final concentration of 0.1 mM. 
INCUBATIONTIME(HRS) 
Fig.2. Effect of NAD on [‘HI thymidine transport and incorpo- 
ration into DNA of tissue slices of differentiating cardiac 
muscle. Tissue slices were prepared from 6-day-old neonatal 
rats. Closed symbols represent hymidine transport; open 
symbols represent hymidine incorporation into DNA. Circles = 
controls, triangles = addition of 1 mM NAD. 
The mechanism for this inhibition remains to be 
determined. In rat embryonic cells incubated with 
NAD labelled at the adenosine moiety with tritium 
and processed for autoradiography, silver grains are 
found almost exclusively over the nucleus indicating 
that NAD, or at least the ADP-ribose moiety, is con- 
centrated in the nucleus [5]. NAD has been reported 
to depress DNA synthesis and template activity of 
chromatin towards exogenous DNA polymerase in 
isolated nuclei and this inhibition is related to the 
ADP-ribosylation of nuclear proteins 16-81. Because 
of the above observations and the data presented in 
this report it is suggested that NAD may play a role 
in repressing DNA synthesis and cell proliferation in 
cardiac muscle during terminal differentiation. This 
repression could occur by the chemical modification 
of chromosomal proteins or possibly nuclear enzymes 
[9-l l] by ADP-ribosylation. 
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